false
0001358190
0001358190
2026-10-07
2026-10-07
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): October
7, 2026
IT TECH PACKAGING, INC.
(Exact name of registrant as specified in its charter)
Nevada
(State or other jurisdiction of incorporation)
| 001-34577 |
|
20-4158835 |
| (Commission File Number) |
|
(IRS Employer Identification No.) |
|
Science Park, Juli Road
Xushui District, Baoding City
Hebei Province, People’s Republic of China |
|
072550 |
| (Address of principal executive offices) |
|
(Zip Code) |
(86) 312-8698215
(Registrant’s telephone number, including
area code)
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
| ☐ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, par value $0.001 per share |
|
ITP |
|
NYSE American LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934
(17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.
As previously disclosed, IT Tech Packaging, Inc. (the “Company”)
received notice from NYSE Regulation that the Company is not in compliance with the continued listing standards of NYSE American LLC (“NYSE
American” or the “Exchange”) as a result of its failure to timely file with the Securities and Exchange Commission (the
“SEC”) its Annual Report on Form 10-K for the year ended December 31, 2025 (the “Form 10-K”), and the Company
subsequently failed to timely file its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026 (together
with the Form 10-K, the “Delayed Filings”). Accordingly, the Company is not in compliance with Sections 134 and 1101 of the
NYSE American Company Guide (the “Company Guide”) and is subject to the procedures set forth in Section 1007 of the Company
Guide.
Under Section 1007 of the Company Guide, a company that is unable to
cure a filing delinquency within the initial six-month period of the maximum 12-month cure period is required to submit an extension request
to the Exchange. On October 1, 2026, the Company submitted an extension request to NYSE Regulation, requesting additional time to regain
compliance with the NYSE American continued listing standards. On October 7, 2026, the Company received a letter (the “Extension
Notice”) from NYSE Regulation informing the Company that NYSE Regulation had accepted the extension request and granted the Company
a plan period through April 15, 2027 (the “New Cure Deadline”) to complete the Delayed Filings and any subsequently delayed
filings with the SEC.
NYSE Regulation staff will review the Company periodically for compliance
with adherence to the milestones in the plan. If the Company does not make progress consistent with the plan during the plan period, or
if the Company does not complete the Delayed Filings and any subsequently delayed filings with the SEC by the end of the maximum 12-month
cure period on April 15, 2027, Exchange staff will initiate delisting proceedings as appropriate. The Company may appeal a staff delisting
determination in accordance with Section 1010 and Part 12 of the Company Guide.
The Company’s common stock will continue to be listed and traded
on NYSE American during the plan period pursuant to the extension, subject to the Company’s compliance with the plan and other applicable
continued listing requirements, and will continue to bear a late filer (“.LF”) indicator until the filing delinquency is cured.
The Company is working diligently to complete the Delayed Filings and currently expects to file them on or before the New Cure Deadline;
however, there can be no assurance that the Delayed Filings will be completed within such period or that the Company will regain compliance
with the NYSE American continued listing standards.
On October 9, 2026, as required by Sections 402 and 1009(e) of the
Company Guide, the Company issued a press release announcing that it is not in compliance with the NYSE American continued listing standards
and that its listing is being continued pursuant to an extension, and disclosing the New Cure Deadline. A copy of the press release is
attached hereto as Exhibit 99.1.
Cautionary Statement Regarding Forward-Looking Statements
This Current Report on Form 8-K contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), including statements regarding the Company’s ability and expected timing to complete the
Delayed Filings and any subsequently delayed filings by April 15, 2027, to make progress consistent with its plan, to regain compliance
with the NYSE American continued listing standards, and for the Company’s common stock to remain listed on NYSE American. The words
“may,” “could,” “should,” “would,” “believe,” “anticipate,” “estimate,”
“expect,” “intend,” “plan,” “target,” “goal,” and similar expressions are
intended to identify forward-looking statements. These statements are subject to significant risks and uncertainties, many of which are
beyond the Company’s control, and actual results may differ materially from those expressed or implied. Further information regarding
these and other risks is included in the Company’s filings with the SEC, including the “Risk Factors” section of its
most recently filed Annual Report on Form 10-K. The Company undertakes no obligation to update any forward-looking statement, except as
required by law.
Item
9.01 Financial Statements and Exhibits.
(d) Exhibits.
The following exhibits are filed herewith:
| Exhibit
Number |
|
Description |
| |
|
|
| 99.1 |
|
Press Release dated October 9, 2026. |
| 104 |
|
Cover Page Interactive Data File (embedded within the
Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
IT TECH PACKAGING, INC. |
| |
|
|
|
| Date: October 9, 2026 |
By: |
/s/ Zhenyong Liu |
| |
|
Name: |
Zhenyong Liu |
| |
|
Title: |
Chief Executive Officer |
Exhibit 99.1
IT Tech Packaging, Inc. Announces NYSE Regulation
Acceptance of Extension Request; Listing Continued Pursuant to Extension Through April 15, 2027
Company granted plan period through April 15,
2027 to complete delayed SEC periodic filings
BAODING, China, October 9, 2026 (PRNewswire)/ -- IT Tech Packaging,
Inc. (NYSE American: ITP) (“ITP” or the “Company”), a leading manufacturer and distributor of diversified paper
products in North China, today announced that it is not in compliance with the continued listing standards of NYSE American LLC (“NYSE
American” or the “Exchange”) and that its listing is being continued pursuant to an extension granted by NYSE Regulation.
The targeted completion date of the plan period (the “New Cure Deadline”) is April 15, 2027.
As previously disclosed, the Company is not in compliance with Sections
134 and 1101 of the NYSE American Company Guide (the “Company Guide”) because it failed to timely file with the U.S. Securities
and Exchange Commission (the “SEC”) its Annual Report on Form 10-K for the year ended December 31, 2025 and its Quarterly
Reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026 (collectively, the “Delayed Filings”).
Pursuant to Section 1007 of the Company Guide, a company that is unable
to cure a filing delinquency within the initial six-month period of the maximum 12-month cure period is required to submit an extension
request. On October 1, 2026, the Company submitted an extension request to NYSE Regulation. On October 7, 2026, the Company received a
letter from NYSE Regulation informing the Company that NYSE Regulation had reviewed and accepted the extension request and granted the
Company a plan period through April 15, 2027 to complete the Delayed Filings and any subsequently delayed filings with the SEC.
NYSE Regulation staff will review the Company periodically for compliance
with adherence to the milestones in the plan. If the Company does not make progress consistent with the plan during the plan period, or
if the Company does not complete the Delayed Filings and any subsequently delayed filings with the SEC by the end of the maximum 12-month
cure period on April 15, 2027, Exchange staff will initiate delisting proceedings as appropriate. The Company may appeal a staff delisting
determination in accordance with Section 1010 and Part 12 of the Company Guide.
The Company’s common stock will continue to be listed and traded
on NYSE American during the plan period, subject to the Company’s compliance with the plan and other applicable continued listing
requirements, and will continue to bear a late filer (“.LF”) indicator until the filing delinquency is cured. The extension
does not have any immediate effect on the listing or trading of the Company’s common stock.
The Company is working diligently to complete the Delayed Filings and
currently expects to file them on or before the New Cure Deadline; however, there can be no assurance that the Company will do so or that
it will regain compliance with the NYSE American continued listing standards.
About IT Tech Packaging, Inc.
Founded in 1996, IT Tech Packaging, Inc. is a
leading manufacturer and distributor of diversified paper products in North China. Using recycled paper as its primary raw material (with
the exception of its tissue paper products), ITP produces and distributes three categories of paper products: corrugating medium paper,
offset printing paper and tissue paper products. With production based in Baoding and Xingtai in North China’s Hebei Province, ITP
is located strategically close the Beijing and Tianjin region, home to a growing base of industrial and manufacturing activities and one
of the largest markets for paper products consumption in the country. ITP has been listed on the NYSE American since December 2009. For
more information, please visit: www.itpackaging.cn.
Forward-Looking Statements
This press release contains “forward-looking statements”
within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the Company’s ability and expected
timing to complete the Delayed Filings and any subsequently delayed filings by April 15, 2027, to make progress consistent with its plan,
to regain compliance with the NYSE American continued listing standards, and for the Company’s common stock to remain listed on
NYSE American. Words such as “may,” “could,” “should,” “would,” “will,” “believe,”
“anticipate,” “estimate,” “expect,” “intend,” “plan,” “target,”
“goal,” and similar expressions are intended to identify forward-looking statements. These statements are subject to significant
risks and uncertainties, many of which are beyond the Company’s control, and actual results may differ materially from those expressed
or implied. Further information regarding these and other risks is included in the Company’s filings with the SEC, including the
“Risk Factors” section of its most recently filed Annual Report on Form 10-K. All forward-looking statements speak only as
of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required
by law.
Contacts:
At the Company Email:
ir@itpackaging.cn
Tel: +86 0312 8698215
